Komori
Transgenic Group (2342) · RiskMaterialised

Trust and Business Continuity Risks from Contract Testing Data Misconduct

First written in FY2025. 5 of 7 entries say "Materialised", first in FY2025. Latest entry: FY2026.

7entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2025 – 2026-05-132025: 220252026: 52026
Same theme, other companies

Transgenic Group moved to the "Worse" side of this theme in 2025.

1 other company's latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「The Company conducted an investigation into the facts surrounding the misconduct involving contract testing data identified at its consolidated subsidiary, トランスジェニック. It recorded ¥34.512 million in extraordinary losses for fees paid to external experts, including attorneys, engaged for the investigation and additional audit fees paid to the accounting auditor.」

    The Company investigated the subsidiary’s testing data misconduct and recorded ¥34.512 million in extraordinary losses for fees paid to external experts, additional audit fees and other expenses.
  2. FY2026-H1MaterialisedAnnual report

    「Interim net income attributable to owners of the parent was ¥29.547 million, after recording ¥37.428 million in extraordinary income, including refunds of consumption taxes and other amounts from prior fiscal years, and ¥64.112 million in extraordinary losses, including business reorganization losses associated with the consolidation of the subsidiary’s locations and special investigation expenses related to the subsidiary’s testing data misconduct.」

    The Company recorded extraordinary losses including ¥29.512 million in special investigation expenses related to the subsidiary’s testing data misconduct, resulting in a financial impact from the misconduct during the interim period as well.
  3. FY2025MaterialisedAnnual report

    「We consider it an urgent priority to restore trust after irregularities involving test data were committed by certain employees in connection with some of the contract testing conducted by our subsidiary, 株式会社トランスジェニック 磐田研究所.」

    Misconduct involving contract testing data was confirmed at the subsidiary’s Iwata Research Center, and the Company itself has identified restoring trust as an urgent priority.
Moved together

"Economic slowdown and rising labor costs due to trade friction and labor shortages" moved the same way as this thread, in the same document, in 3 of its 7 moves.

3222★1234
  1. ★This thread
  2. 1Economic slowdown and rising labor costs due to trade friction and labor shortages3×
  3. 2Shareholder return policy aimed at establishing a dividend-paying structure while prioritizing investment and research and development2×
  4. 3Risks of Unforeseen Problems and Goodwill Impairment Associated with Business Alliances and Corporate Acquisitions2×
  5. 4A later timing of revenue recognition due to an increase in overseas projects and the larger scale and longer duration of contracted testing2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Transgenic Group yet. It last moved in the General Meetings of Shareholders of 2026-05-28: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Trust and Business Continuity Risks from Contract Testing Data Misconduct | TRANSGENIC GROUP INC. (2342) | Komori